CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Operating Activities
Net earnings	$ 301,045	$ 303,790
Loss on assets held for sale	0	46,946
Adjustments to reconcile net earnings to cash from operating activities:
Depreciation and amortization	136,355	135,507
Share-based compensation expense	8,220	16,617
Gain on sale of businesses	(5,770)	0
Other, net	(9,021)	(5,373)
Cash effect of changes in assets and liabilities (excluding effects of acquisitions, dispositions and foreign exchange):
Accounts receivable, net	73,317	(63,228)
Inventories	(80,883)	(93,554)
Prepaid expenses and other assets	(12,975)	(23,359)
Accounts payable	(72,009)	(7,128)
Accrued compensation and employee benefits	(63,621)	(50,246)
Accrued expenses and other liabilities	55,736	(20,915)
Accrued and deferred taxes, net	17,278	(5,824)
Net cash provided by operating activities	347,672	233,233
Investing Activities
Additions to property, plant and equipment	(79,171)	(91,092)
Acquisitions, net of cash acquired	(238,839)	(215,304)
Proceeds from sale of property, plant, and equipment	2,886	2,633
Proceeds from sale of businesses	16,850	24,218
Other	0	(7,900)
Net cash (used in) provided by investing activities	(298,274)	(287,445)
Financing Activities
Repurchase of common stock, including prepayment under an accelerated share repurchase program	(52,916)	0
Change in commercial paper and notes payable	420,300	137,350
Dividends paid to stockholders	(141,570)	(139,730)
Payments to settle employee tax obligations on exercise of share-based awards	(11,217)	(21,209)
Other	(1,101)	(940)
Net cash used in by financing activities	213,496	(24,529)
Effect of Exchange Rate on Cash and Cash Equivalents	(11,115)	3,846
Net (decrease) increase in cash and cash equivalents	251,779	(74,895)
Cash and cash equivalents at beginning of period	397,253	396,221
Cash and cash equivalents at end of period	$ 649,032	$ 321,326